ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Doctors, clinical officers, nurses, laboratory technologists, pharmacists, community health workers and staff funded by the US Government have been impacted. Service Disruptions: Some facilities ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Medically reviewed by Edmund Khoo, DDS Thrush, or oral candidiasis, is a fungal infection in your mouth and throat. It is ...

Speaking of films, we’ve got a preview of Out On Film’s Spring Mini-Fest in today’s newsletter, along with a look at a vital HIV support group for women, and the return of Maria Helena Dolan’s Reeling ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

To learn more, please visit www.reprievetrial.org.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Toxoplasmosis and MDD were among several preexisting comorbidities associated with the development of neurocognitive disorders in patients with HIV infection.

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...